Supplementary Tables from Identification of Multiple Mechanisms of Resistance to Vemurafenib in a Patient with BRAF&lt;sup&gt;V600E&lt;/sup&gt;-Mutated Cutaneous Melanoma Successfully Rechallenged after Progression